Steris (STE) EBITDA (2018 - 2026)

Steris' EBITDA history runs 9 years deep, the most recent figure standing at $316.8 million for Q1 2026.

• On a quarterly basis, EBITDA rose 46.6% year-over-year to $316.8 million in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 27.14% increase from a year earlier, with the FY2026 full-year figure at $1.1 billion, up 27.14% from the prior year.
• EBITDA rose to $316.8 million in Q1 2026 per STE's latest filing, from $273.2 million in the prior quarter.
• Across five years, EBITDA topped out at $748.3 million in Q1 2023 and bottomed at -$306.4 million in Q3 2022.
• The 5-year median for EBITDA is $219.7 million (2024), against an average of $220.0 million.
• Biggest YoY gain for EBITDA was 68697.62% in 2022; the steepest drop was 363.01% in 2022.
• Year by year, EBITDA stood at $190.8 million in 2022, then rose by 18.69% to $226.5 million in 2023, then advanced by 8.31% to $245.3 million in 2024, then rose by 11.37% to $273.2 million in 2025, then climbed by 15.96% to $316.8 million in 2026.
• Per Business Quant, the three latest STE EBITDA figures stand at $316.8 million (Q1 2026), $273.2 million (Q4 2025), and $265.8 million (Q3 2025).